-+ 0.00%
-+ 0.00%
-+ 0.00%

BRISTOL MYERS SQUIBB CANADA WELCOMES POSITIVE CDA RECOMMENDATION FOR OPDIVO® PLUS YERVOY® AS FIRST-LINE TREATMENT FOR MSI-H/DMMR METASTATIC COLORECTAL CANCER

Reuters·12/17/2025 12:00:42

Please log in to view news